Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesElixxer Ltd

Elixxer Ltd

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
None CAD 0.00(0%)
Last update at 2026-11-04T21:00:11.041153Z
Market Cap
13.05M

Momentum Score

…

Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
1.15
Low
1.15
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Elixxer Ltd is listed on the TSX Venture Exchange (ELXR.V); publicly available information about its operations is limited. The company's core business and long-term growth drivers are not clearly documented in public filings or press releases. Investors may benefit if management articulates and executes a credible strategy, but they should consult the company's filings and direct communications for authoritative details.

Key investment risks include scarce disclosure and transparency, low trading liquidity, small-cap financing and execution risk, and industry or regulatory developments that could materially affect prospects.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.04M
Debt / Equity
-
ROE
-1013.76%
Net Debt
11.89M
ROCE
3.74%
Diluted EPS TTM
-1.02

Insight Announcement

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -3.47M -4.01M -14.09M -3.66M -9.78M
Net income -3.47M -4.01M -14.17M -3.66M -9.78M
Selling general administrative 0.49M 1.28M 2.22M 2.07M 3.29M
Reconciled depreciation - - 0.00M 0.00M 0.00M
Ebit - - - -2.10M -5.44M
Ebitda - - -11.64M -1.94M -7.72M
Operating income -0.49M -1.28M -2.42M -2.10M -5.44M
Interest expense 2.22M 2.61M 2.45M 1.72M 2.06M
Interest income - 0.00M 0.08M 0.04M 1.09M
Net interest income -2.22M -2.61M -3.06M -1.68M -1.61M
Total revenue 0.00M 0.00M 0.08M 0.00M 0.02M
Total operating expenses 0.49M 1.28M 2.51M 2.10M 5.46M
Total other income expense net -0.76M -0.12M -8.60M 0.12M -2.73M
Net income from continuing ops -3.47M -4.01M -14.09M -3.66M -9.78M
Net income applicable to common shares - - -14.17M -3.66M -9.78M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 2.13M 2.81M 5.37M 16.84M 20.81M
Total liab 15.23M 12.41M 10.95M 8.45M 16.06M
Total stockholder equity -13.09M -9.60M -5.58M 8.38M 4.76M
Common stock - - - 53.26M 49.57M
Capital stock 53.44M 53.44M 53.44M 53.26M 49.57M
Retained earnings -87.98M -84.51M -80.50M -66.33M -62.67M
Other assets - - - 0.32M 0.36M
Cash 0.02M 0.02M 0.07M 0.30M 2.10M
Total current liabilities 15.23M 12.41M 7.34M 8.45M 16.06M
Net debt 11.89M 9.64M 7.96M 6.24M 10.99M
Short long term debt 11.91M 9.66M 4.41M 6.54M 13.09M
Other stockholder equity - - 4.04M 4.79M 4.33M
Property plant equipment - - - - 0.01M
Total current assets 0.07M 0.03M 2.53M 13.70M 2.33M
Long term investments 0.82M 0.75M 2.84M 0.69M 15.99M
Net tangible assets - - - 8.38M 4.76M
Short term investments - 0.00M 2.41M 13.28M -
Net receivables - - - 0.11M 0.22M
Long term debt - - 3.61M - -
Accounts payable - - 2.93M 1.89M 1.54M
Non current assets total 2.06M 2.78M 2.84M 3.14M 18.49M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 0.00M 2.35M 2.32M 2.19M 1.06M
Change to liabilities - - 1.02M -1.00M 0.54M
Total cashflows from investing activities - - - 2.19M 1.06M
Net borrowings - 0.00M 1.04M 0.16M 2.74M
Total cash from financing activities - 0.00M 0.46M 0.03M 3.13M
Net income -3.47M -4.01M -14.17M -3.66M -9.78M
Change in cash 0.00M -0.05M -0.24M -1.80M 1.18M
Begin period cash flow 0.02M 0.07M 0.30M 2.10M 0.92M
End period cash flow 0.02M 0.02M 0.07M 0.30M 2.10M
Total cash from operating activities 0.00M -2.40M -3.02M -4.02M -3.01M
Issuance of capital stock - - - 0.00M 0.40M
Depreciation - - 0.00M 0.00M 0.00M
Change to account receivables - - 0.11M 0.17M -0.12M
Sale purchase of stock - 0.00M -0.58M -0.13M -
Other cashflows from financing activities - - - - 0.26M
Change to netincome - - - 0.48M 6.35M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.52M -0.09M 1.13M -0.84M 0.42M
Stock based compensation - - 0.00M 0.00M 0.41M
Other non cash items 2.22M 2.61M 1.11M 0.54M 9.50M
Free cash flow 0.00M -2.40M -3.02M -4.02M -3.01M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RX
Biosyent Inc.		 0.30
1.78%		 17.15 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 0.21
11.67%		 2.01 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 0.03
9.38%		 0.35 - - 108.48 4.41 140.29 -4.26
LSL
LSL Pharma Group Inc.		 0.01
1.64%		 0.31 20.75 - 1.88 1.89 2.85 10.19

Profile*

Elixxer Ltd

Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.

1100 Boulevard Rene- Levesque Ouest, Montreal, QC, Canada, H5B 4N4

514 788 1499

https://www.elixxer.com

Name Title Year Born
Mr. Ferras Zalt Chairman & Interim CEO 1963
Ms. Kym No C.M.A., CPA Corp. Controller & Interim CFO NA
Mr. Guy Charette L.L.B., LL.B. Legal Council 1954
Ms. Jeanne van Wyk VP of Communications NA
Mr. Daniel Lubienietzky VP of Corp. Devel. NA
Mr. Richard Widmann EVP of Commercial 1968
Mr. Michael Kozub Corp. Sec. NA
Ms. Kym No C.M.A., CPA Corporate Controller & Interim CFO NA
Ms. Jeanne van Wyk Vice President of Communications NA
Mr. Daniel Lubienietzky VP of Corporate Development NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…